AllianceBernstein’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-41,700
| Closed | -$477K | – | 3363 |
|
|
2020
Q4 | $477K | Sell |
41,700
-1,700
| -4% | -$19.4K | ﹤0.01% | 2621 |
|
|
2020
Q3 | $299K | Hold |
43,400
| – | – | ﹤0.01% | 2812 |
|
|
2020
Q2 | $283K | Buy |
43,400
+5,300
| +14% | +$34.2K | ﹤0.01% | 2907 |
|
|
2020
Q1 | $252K | Buy |
38,100
+4,600
| +14% | +$40.1K | ﹤0.01% | 2705 |
|
|
2019
Q4 | $347K | Hold |
33,500
| – | – | ﹤0.01% | 2723 |
|
|
2019
Q3 | $212K | Buy |
33,500
+1,600
| +5% | +$11.9K | ﹤0.01% | 2929 |
|
|
2019
Q2 | $237K | Buy |
31,900
+4,600
| +17% | +$30.3K | ﹤0.01% | 2914 |
|
|
2019
Q1 | $168K | Buy |
27,300
+7,100
| +35% | +$82.3K | ﹤0.01% | 2940 |
|
|
2018
Q4 | $233K | Buy |
20,200
+1,600
| +9% | +$27.3K | ﹤0.01% | 2833 |
|
|
2018
Q3 | $403K | Buy |
18,600
+1,500
| +9% | +$28.4K | ﹤0.01% | 2719 |
|
|
2018
Q2 | $270K | Buy |
17,100
+500
| +3% | +$7.86K | ﹤0.01% | 2857 |
|
|
2018
Q1 | $313K | Buy |
16,600
+1,400
| +9% | +$27.6K | ﹤0.01% | 2677 |
|
|
2017
Q4 | $264K | Buy |
15,200
+1,300
| +9% | +$17.9K | ﹤0.01% | 2770 |
|
|
2017
Q3 | $208K | Hold |
13,900
| – | – | ﹤0.01% | 2923 |
|
|
2017
Q2 | $258K | Buy |
13,900
+400
| +3% | +$6.95K | ﹤0.01% | 2883 |
|
|
2017
Q1 | $228K | Hold |
13,500
| – | – | ﹤0.01% | 2809 |
|
|
2016
Q4 | $287K | Hold |
13,500
| – | – | ﹤0.01% | 2760 |
|
|
2016
Q3 | $247K | Buy |
13,500
+3,900
| +41% | +$87.9K | ﹤0.01% | 2771 |
|
|
2016
Q2 | $278K | Buy |
+9,600
| New | +$267K | ﹤0.01% | 2708 |
|
AllianceBernstein's ARA Position: Q1 2021 in Review
AllianceBernstein sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 41,700 shares — an estimated $477K sold.
AllianceBernstein first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $477K in Q4 2020. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- AllianceBernstein reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- AllianceBernstein sold 41,700 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $477K.
- AllianceBernstein first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- AllianceBernstein's American Renal Associates Holdings, Inc position peaked at $477K in Q4 2020.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on AllianceBernstein's 13F filing for Q1 2021, filed 6 May 2021.